Charles University in Prague, Faculty of Pharmacy in Hradec Králové Department: Department of Pharmacology and Toxicology Candidate: Mgr. Tomáš Filipský First supervisor: prof. MUDr. Radomír Hrdina, CSc. Second supervisor: PharmDr. Přemysl Mladěnka, Ph.D. Title of doctoral thesis: Screening of iron-chelating substances and their potential use in the therapy of acute myocardial infarction Iron is an essential element virtually for all living organisms. The concentration of free/unbound iron is very low at physiological conditions. However, in several pathological states, its homeostasis is impaired which may lead to an organ damage due to the increased production of reactive oxygen species. Coronary heart disease is the main cause of morbidity and mortality worldwide. Its most serious form is acute myocardial infarction (AMI). During the early ischaemia, catalytically active elements, particularly iron and copper, are released into the blood circulation. After restoration of blood flow (reperfusion), these elements may participate in the production of biologically the most potent oxidant - hydroxyl radical via iron/copper catalysed Fenton reaction. Therefore, a therapy based on administration of iron/copper-chelating agents could be a potential pharmacotherapeutic approach in the treatment of this..
